We thank Ertem et al 1 for their interest in our paper entitled ''Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare-Metal Stent''. 2 We found that serum albumin (SA) level at admission is inversely associated with in-stent restenosis (ISR) in patients with stable angina pectoris (SAP). As we mentioned in the methods section, we enrolled 366 consecutive patients with SAP who previously underwent successful bare-metal stent (BMS) implantation. We excluded 25 patients, and the remaining 341 eligible patients with SAP were included in the study. The final study population consisted of patients with a history of BMS implantation who previously presented with acute coronary syndrome (n ¼ 145) or SAP (n ¼ 196) and treated with BMS. We performed coronary angiography for all of these 341 patients with SAP owing to clinical indications, including symptoms of angina and abnormal stress test results, by either exercise treadmill tests or myocardial perfusion scintigraphy. Therefore, all of these patients were assessed as stable coronary artery disease. Furthermore, the patients were mainly classified into 2 groups: ISR group and no-ISR group, and we analyzed the SA levels separately. We showed that SA levels were significantly lower in patients with ISR compared with those without ISR (3.69 + 0.41 mg/dL vs 4.07 + 0.35 mg/dL, respectively; P < .001). We will keep in mind that future studies can be designed more clearly.
